DiaSorin LIAISON® MeMed BV® The innovative new solution for accurate and rapid differentiation between bacterial and viral infections Increased antimicrobial resistance is one of the key healthcare challenges around the world. Largely driven by the overuse of antibiotics, it often results from the misdiagnosis of disease etiology due to the difficulty in quickly identifying whether an infection is viral or bacterial. This not only alters the trajectory of patient care, it can lead to potentially detrimental consequences for the patient, the healthcare system and society. By helping physicians quickly and accurately differentiate between bacterial and viral infections, DiaSorin’s new LIAISON® MeMed BV® chemiluminescent serology technology delivers a concrete solution to reaching more-informed patient management decisions. LIAISON® MeMed BV® easily and automatically confirms the source of a patient’s infection. It is the first high-throughput, high-quality CLIA test designed to quickly differentiate between bacterial and viral infections in a single procedure using the automated LIAISON® family of analyzers. The innovative solution integrates three key host-immune protein measurements (TRAIL, IP-10 and CRP) with a powerful machine learning algorithm, to produce fast, standardized and straightforward diagnostic results. LIAISON® MeMed BV® – supporting your decision-making while fighting the problem of antimicrobial resistance. CLIA LIAISON® MeMed BV® HOME COMPANY CLINICAL AREAS Infectious Diseases Hepatitis and Retrovirus TORCH EBV MMRV Borrelia LymeDetect® Respiratory Infections Sepsis Tuberculosis Other Infectious Diseases Zika COVID-19 LIAISON® MeMed BV® Bone and Mineral Endocrinology Hypertension Oncology Stool Diagnostics Autoimmunity SYSTEMS COMMITTED TO EFFICIENCY NEWS EVENTS WORLDWIDE CONTACTS New Labeling & Packaging Download DiaSorin app for laboratories Diasorin Group Diasorin Molecular Luminex Corporation Legal Notices Privacy Policy Modern Slavery Act Statement DiaSorin S.p.A. - Share Capital € 55.948.257 R.E.A. 180729 Fiscal Code and Subscription to Vercelli Companies Register no 13144290155 English Italiano INTERNATIONAL USA Disclaimer: the DIASORIN site content linked here is for outside the United States only. Continue to our International Section Disclaimer: the DIASORIN site content linked here is for United States only. Continue to our US Section Ai sensi delle Linee Guida del Ministero della Salute del 28/03/2013, relative alla pubblicità sanitaria concernente i dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici, si avvisa l'utente che le informazioni contenute nel presente sito Internet e alle quali si sta per accedere sono esclusivamente rivolte agli operatori professionali Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professional operators